NEW YORK, Feb. 13 - Hyseq on Wednesday said that it will license technology from Genetastix to generate fully human monoclonal antibodies against one of its antigens.

Terms of their agreement call for Hyseq to give Genetastix an upfront payment as well as research and development payments to use its HuMYTech technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.